The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
The Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular Calcification
Open accessAbstract
AGE/RAGE signaling has been a well-studied cascade in many different disease states, particularly diabetes. Due to the complex nature of the receptor and multiple intersecting pathways, the AGE/RAGE signaling mechanism is still not well understood. The purpose of this review is to highlight key areas of AGE/RAGE mediated vascular calcification as a complication of diabetes. AGE/RAGE signaling heavily influences both cellular and systemic responses to increase bone matrix proteins through PKC, p38 MAPK, fetuin-A, TGF-β, NF κ B, and ERK1/2 signaling pathways in both hyperglycemic and calcification conditions. AGE/RAGE signaling has been shown to increase oxidative stress to promote diabetes-mediated vascular calcification through activation of Nox-1 and decreased expression of SOD-1. AGE/RAGE signaling in diabetes-mediated vascular calcification was also attributed to increased oxidative stress resulting in the phenotypic switch of VSMCs to osteoblast-like cells in AGEs-induced calcification. Researchers found that pharmacological agents and certain antioxidants decreased the level of calcium deposition in AGEs-induced diabetes-mediated vascular calcification. By understanding the role the AGE/RAGE signaling cascade plays diabetes-mediated vascular calcification will allow for pharmacological intervention to decrease the severity of this diabetic complication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y.-H., Inada, M., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80258-5 · Cited by 4,244
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
Oxidative stress, insulin signaling, and diabetes
Rains, J. L., & Jain, S. K. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.006 · Cited by 1,435
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Vascular Calcification: Pathobiology of a Multifaceted Disease
Demer, L. L., & Tintut, Y. (2008) · Circulation · doi:10.1161/circulationaha.107.743161 · Cited by 1,065
Sodek, J., Ganss, B., & McKee, M. D. (2000) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411000110030101 · Cited by 993
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
Geraldes, P., & King, G. L. (2010) · Circulation Research · doi:10.1161/circresaha.110.217117 · Cited by 985
Vascular Calcification: Pathobiological Mechanisms and Clinical Implications
Johnson, R. C., Leopold, J. A., & Loscalzo, J. (2006) · Circulation Research · doi:10.1161/01.res.0000249379.55535.21 · Cited by 944
Schäfer, C., Heiss, A., Schwarz, A., Westenfeld, R., Ketteler, M., Floege, J., Müller-Esterl, W., Schinke, T., & Jahnen-Dechent, W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17202 · Cited by 924
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., Mukhopadhyay, S., Ray, S., Majumdar, S. S., & Bhattacharya, S. (2012) · Nature Medicine · doi:10.1038/nm.2851 · Cited by 922 · cited 1×
“showed that fetuin-A can act as a ligand to TLR-4 to stimulate FFAinduced insulin resistance in adipocytes [47].”
BackgroundReynolds, J. L., Joannides, A. J., Skepper, J. N., McNair, R., Schurgers, L. J., Proudfoot, D., Jahnen-Dechent, W., Weissberg, P. L., & Shanahan, C. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141960.01035.28 · Cited by 911
Ketteler, M., Bongartz, P., Westenfeld, R., Wildberger, J. E., Mahnken, A. H., Böhm, R., Metzger, T., Wanner, C., Jahnen-Dechent, W., & Floege, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12710-9 · Cited by 910
Steitz, S. A., Speer, M. Y., Curinga, G., Yang, H.-Y., Haynes, P., Aebersold, R., Schinke, T., Karsenty, G., & Giachelli, C. M. (2001) · Circulation Research · doi:10.1161/hh2401.101070 · Cited by 822
Proudfoot, D., Skepper, J. N., Hegyi, L., Bennett, M. R., Shanahan, C. M., & Weissberg, P. L. (2000) · Circulation Research · doi:10.1161/01.res.87.11.1055 · Cited by 719
The Mechanism of Mineralization and the Role of Alkaline Phosphatase in Health and Disease
Orimo, H. (2010) · Journal of Nippon Medical School · doi:10.1272/jnms.77.4 · Cited by 718
Nucleation of hydroxyapatite by bone sialoprotein.
Hunter, G. K., & Goldberg, H. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8562 · Cited by 665
Lehto, S., Niskanen, L., Suhonen, M., Rönnemaa, T., & Laakso, M. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.8.978 · Cited by 594
Vascular Calcification Mechanisms
Giachelli, C. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000145894.57533.c4 · Cited by 583
Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition
Hameed, I., Masoodi, S. R., Mir, S. A., Nabi, M., Ghazanfar, K., & Ganai, B. A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i4.598 · Cited by 506
RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages
Kokkola, R., Andersson, Å., Mullins, G., Östberg, T., Treutiger, C. ‐., Arnold, B., Nawroth, P., Andersson, U., Harris, R. A., & Harris, H. E. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2005.01534.x · Cited by 496
Ganss, B., Kim, R. H., & Sodek, J. (1999) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411990100010401 · Cited by 489
Structural Basis of Calcification Inhibition by α2-HS Glycoprotein/Fetuin-A
Heiss, A., DuChesne, A., Denecke, B., Grötzinger, J., Yamamoto, K., Renné, T., & Jahnen-Dechent, W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210868200 · Cited by 472
Oxidative stress and glutathione in TGF-β-mediated fibrogenesis
Liu, R.-M., & Gaston Pravia, K. A. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.09.026 · Cited by 469
Vascular Calcification: An Update on Mechanisms and Challenges in Treatment
Wu, M., Rementer, C., & Giachelli, C. M. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9712-z · Cited by 434
Weinreb, M., Shinar, D., & Rodan, G. A. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050806 · Cited by 434
Plasma fetuin-A levels and the risk of type 2 diabetes
Stefan, N., Fritsche, A., Weikert, C., Boeing, H., Joost, H.-G., Häring, H.-U., & Schulze, M. B. (2008) · Diabetes · doi:10.2337/db08-0538 · Cited by 379
Moe, S. M., Reslerova, M., Ketteler, M., O'Neill, K., Duan, D., Koczman, J., Westenfeld, R., Jahnen-Dechent, W., & Chen, N. X. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00333.x · Cited by 366
Bone Morphogenetic Proteins in Vascular Calcification
Hruska, K. A., Mathew, S., & Saab, G. (2005) · Circulation Research · doi:10.1161/01.res.00000175571.53833.6c · Cited by 360
Schinke, T., Amendt, C., Trindl, A., Pöschke, O., Müller-Esterl, W., & Jahnen-Dechent, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20789 · Cited by 356
Lee, K.-S., Hong, S.-H., & Bae, S.-C. (2002) · Oncogene · doi:10.1038/sj.onc.1205937 · Cited by 346
Reynolds, J. L., Skepper, J. N., McNair, R., Kasama, T., Gupta, K., Weissberg, P. L., Jahnen-Dechent, W., & Shanahan, C. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100895 · Cited by 337
Stitt, A. W., Li, Y. M., Gardiner, T. A., Bucala, R., ARCHER, D. B., & Vlassara, H. (1997) · Europe PMC (PubMed Central) · Cited by 324
Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels
Moe, S. M., Duan, D., Doehle, B. P., O'Neill, K. D., & Chen, N. X. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00820.x · Cited by 321
A current understanding of vascular calcification in CKD
Paloian, N. J., & Giachelli, C. M. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00163.2014 · Cited by 321
Li, J. H., Huang, X. R., Zhu, H., Oldfield, M., Cooper, M., Truong, L. D., Johnson, R. J., & Lan, H. Y. (2004) · The FASEB Journal · doi:10.1096/fj.02-1117fje · Cited by 264
Sakaguchi, M., Murata, H., Yamamoto, K.-I., Ono, T., Sakaguchi, Y., Motoyama, A., Hibino, T., Kataoka, K., & Huh, N.-H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023132 · Cited by 228
The role of osteocalcin in human glucose metabolism: marker or mediator?
Booth, S. L., Centi, A., Smith, S. R., & Gundberg, C. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.201 · Cited by 227
Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond
Daffu, G., Del Pozo, C., O'Shea, K., Ananthakrishnan, R., Ramasamy, R., & Schmidt, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141019891 · Cited by 222
Chen, N. X., Duan, D., O'Neill, K. D., & Moe, S. M. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl429 · Cited by 202
Activation of p38 Mitogen-Activated Protein Kinase Is Required for Osteoblast Differentiation
Hu, Y., Chan, E., Wang, S. X., & Li, B. (2003) · Endocrinology · doi:10.1210/en.2002-220863 · Cited by 198
Tanikawa, T., Okada, Y., Tanikawa, R., & Tanaka, Y. (2009) · Journal of Vascular Research · doi:10.1159/000226225 · Cited by 191
Transforming growth factor β signaling mediators and modulators
Zimmerman, C. M., & Padgett, R. W. (2000) · Gene · doi:10.1016/s0378-1119(00)00162-1 · Cited by 174
Anti-Inflammatory Role of Fetuin-A in Injury and Infection
Wang, H., & Sama, A. (2012) · Current Molecular Medicine · doi:10.2174/156652412800620039 · Cited by 154
Bone matrix mRNA expression in differentiating fetal bovine osteoblasts
Ibaraki, K., Termine, J. D., Whitson, S. W., & Young, M. F. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070704 · Cited by 151
Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress
Qin, W. D., Ren, X., Jiang, Y., Jin, H. L., Liu, N., & Li, J. (2013) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-13-13 · Cited by 145
Stitt, A. W., Moore, J. E., Sharkey, J. A., Murphy, G., Simpson, D. A. C., Bucala, R., Vlassara, H., & ARCHER, D. B. (1998) · PubMed · Cited by 137
Chen, N. X., Duan, D., O’Neill, K. D., Wolisi, G. O., Koczman, J. J., LaClair, R. E., & Moe, S. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001663 · Cited by 137
Takemoto, M., Yokote, K., Nishimura, M., Shigematsu, T., Hasegawa, T., Kon, S., Uede, T., Matsumoto, T., Saitō, Y., & Mori, S. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.624 · Cited by 109
Srivastava, A. K. (2002) · International Journal of Molecular Medicine · doi:10.3892/ijmm.9.1.85 · Cited by 101
Yang, Y., Cui, Q., & Sahai, N. (2010) · Langmuir · doi:10.1021/la100192z · Cited by 101
Mechanisms of Vascular Calcification
El‐Abbadi, M. M., & Giachelli, C. M. (2007) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2006.10.007 · Cited by 99
Suga, T., Iso, T., Shimizu, T., Tanaka, T., Yamagishi, S., Takeuchi, M., Imaizumi, T., & Kurabayashi, M. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.7120 · Cited by 90
Brodeur, M. R., Bouvet, C., Bouchard, S., Moreau, S., Chain, J. L., deBlois, D., & Moreau, P. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085922 · Cited by 88
Hutchinson, K. R., Lord, C. K., West, T. A., & Stewart, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072080 · Cited by 88
Self-citationSerum Fetuin-A Associates with Type 2 Diabetes and Insulin Resistance in Chinese Adults
Song, A., Xu, M., Bi, Y., Xu, Y., Huang, Y., Li, M., Wang, T., Wu, Y., Liu, Y., Li, X., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019228 · Cited by 85
Advanced Glycation End-products Enhance Calcification in Vascular Smooth Muscle Cells
Ren, X., Shao, H., Wei, Q., Sun, Z., & Liu, N. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700329 · Cited by 71
Role of fetuin-A in atherosclerosis associated with diabetic patients
Singh, M., Sharma, P. K., Garg, V. K., Mondal, S. C., Singh, A. K., & Kumar, N. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01561.x · Cited by 70
A multicellular signal transduction network of AGE/RAGE signaling
Soman, S., Raju, R., Sandhya, V. K., Advani, J., Khan, A. A., Gowda, H., Prasad, T. S. K., Sudhakaran, P. R., Pandey, A., & Adishesha, P. K. (2012) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-012-0181-3 · Cited by 64
AGE-RAGE signal generates a specific NF-κB RelA “barcode” that directs collagen I expression
Peng, Y., Kim, J.-M., Park, H.-S., Yang, A., Islam, C., Lakatta, E. G., & Li, L. (2016) · Scientific Reports · doi:10.1038/srep18822 · Cited by 57
Simard, É., Söllradl, T., Maltais, J., Boucher, J., D’Orléans-Juste, P., & Grandbois, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128881 · Cited by 53
Enhanced Expression of Osteopontin by High Glucose in Cultured Rat Aortic Smooth Muscle Cells
Takemoto, M., Yokote, K., Yamazaki, M., Ridall, A. L., Butler, W. T., Matsumoto, T., Tamura, K., Saitō, Y., & Mori, S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0701 · Cited by 51
Hyperglycemia-induced alteration of vascular smooth muscle phenotype
Mori, S., Takemoto, M., Yokote, K., et al. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00189-1 · Cited by 45
Janda, K., Krzanowski, M., Gajda, M., Dumnicka, P., Jasek-Gajda, E., Fedak, D., Pietrzycka, A., Kuźniewski, M., Litwin, J. A., & Sułowicz, W. (2015) · Disease Markers · doi:10.1155/2015/153978 · Cited by 35
Fetuin-A adsorption and stabilization of calcium carbonate nanoparticles in a simulated body fluid
Vasquez, E. S., Cunningham, J. L., McMahan, J., Simpson, C. L., & Walters, K. B. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00565e · Cited by 20
Self-citationHyperglycaemia and cardiovascular risk
Palumbo, F., Bianchi, C., Miccoli, R., & Prato, S. D. (2003) · Acta Diabetologica · doi:10.1007/s00592-003-0121-z · Cited by 16
Cited by
Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
Khalid, M., Petroianu, G., & Adem, A. (2022) · Biomolecules · doi:10.3390/biom12040542 · Cited by 879
González, P., Lozano, P., Ros, G., & Solano, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119352 · Cited by 777
Yahagi, K., Kolodgie, F. D., Lutter, C., Mori, H., Romero, M. E., Finn, A. V., & Virmani, R. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.306256 · Cited by 573
NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes
Suryavanshi, S. V., & Kulkarni, Y. A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00798 · Cited by 348
Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases
Vona, R., Gambardella, L., Cittadini, C., Straface, E., & Pietraforte, D. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8267234 · Cited by 331
Metadata
- Authors
- Kay, A. M., Simpson, C. L., & Stewart, J. A.
- Venue
- Journal of Diabetes Research
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-8
- ISSN
- 2314-6745 (ISSN-L)
- 2314-6753
- OpenAlex
- W2501497123
- Cited by
- 346
- References
- 68
- FWCI
- 12.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.